Search results for "adjunctive therapy"

showing 2 items of 2 documents

The effects of sugar-free chewing gums on dental plaque regrowth: a comparative study

2006

Abstract Sugar-free chewing gum has been claimed to be a useful means of reducing dental plaque accumulation. The incorporation of additives, such as enzymes, abrasives and divalent metal ions, into gum formulations might improve their antiplaque activity, particularly at the buccal and lingual surfaces of the teeth. Objectives The aim of this study was to investigate the plaque inhibitory effects of three sugar-free chewing gums each containing lactoperoxidase (LP), micro granules of silicon dioxide (SD), and zinc gluconate (ZG). Methods The study was an observer-masked, randomized cross-over design balanced for carryover effects, involving 12 healthy volunteers in a 4-day plaque regrowth …

AdultMaleTime FactorsMaterials scienceDental PlaqueDentistryDental plaqueGluconatesOral hygieneChewing GummedicineHumansSingle-Blind MethodLactoperoxidaseGeneral DentistryFluorescent DyesOrthodonticsCross-Over Studiesbusiness.industryDental Plaque IndexLactoperoxidaseBuccal administrationSilicon Dioxidemedicine.diseaseChewing gumCrossover studyDental Plaque IndexZincstomatognathic diseasesSugar freeErythrosineSweetening AgentsFemalebusinessChewing gum Dental plaque Oral hygiene Adjunctive therapy
researchProduct

Addition of a fixed combination of brinzolamide 1%/timolol 0.5% to prostaglandin monotherapy in patients with glaucoma or ocular hypertension

2011

Katrin Lorenz1, Klaus Rosbach2, Andreas Matt3, Norbert Pfeiffer11University Medical Center, Johannes Gutenberg-Universität Mainz, Mainz, Germany; 2Private practice, Mainz, Germany; 3Private practice, Köln-Hohenhaus, GermanyBackground: This study was conducted to evaluate the safety and efficacy of adding a fixed combination of brinzolamide 1%/timolol 0.5% to prostaglandin analog (PGA) monotherapy in patients with primary open-angle glaucoma, pigment dispersion glaucoma, or ocular hypertension who require additional intraocular pressure (IOP) reduction.Methods: This was a prospective, multicenter (n = 5), open-label, single-arm, Phase IV clinical trial in which patients cur…

Intraocular pressuremedicine.medical_specialtygenetic structuresadjunctive therapyfixed combinationBrinzolamideTimololGlaucomaOcular hypertensionOphthalmologyMedicineAdverse effectcarbonic anhydrase inhibitorOriginal Researchbusiness.industryClinical OphthalmologyRE1-994medicine.diseasebrinzolamideeye diseasesDiscontinuationOphthalmologyProstaglandin analogglaucomasense organsbusinessmedicine.drugintraocular pressureClinical Ophthalmology
researchProduct